Search Results - "Laserson, K. F"

Refine Results
  1. 1

    Development of a TB vaccine trial site in Africa and lessons from the Ebola experience by Kaguthi, G, Nduba, V, Rabuogi, P, Okelloh, D, Ouma, S. G, Blatner, G, Gelderbloem, S, Mitchell, Ellen M. H, Scott, Cherise P, Verver, S, Hawkridge, T, de Steenwinkel, J. E. M, Laserson, K. F, Richardus, J. H

    Published in BMC public health (26-06-2020)
    “…Tuberculosis is the deadliest infection of our time. In contrast, about 11,000 people died of Ebola between 2014 and 2016. Despite this manifest difference in…”
    Get full text
    Journal Article
  2. 2

    Alcohol use, drunkenness and tobacco smoking in rural western Kenya by Lo, T. Q., Oeltmann, J. E., Odhiambo, F. O., Beynon, C., Pevzner, E., Cain, K. P., Laserson, K. F., Phillips‐Howard, P. A.

    Published in Tropical medicine & international health (01-04-2013)
    “…Objectives To describe the prevalence of smoking and alcohol use and abuse in an impoverished rural region of western Kenya. Methods Picked from a…”
    Get full text
    Journal Article
  3. 3

    Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002 by SHEAN, K. P, WILLCOX, P. A, SIWENDU, S. N, LASERSON, K. F, GROSS, L, KAMMERER, S, WELLS, C. D, HOLTZ, T. H

    “…SETTING: Brooklyn Chest Hospital, Western Cape, South Africa.OBJECTIVE: To evaluate the treatment outcome and 2- and 5-year follow-up of patients treated for…”
    Get full text
    Journal Article
  4. 4

    Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis by LASERSON, K. F, THORPE, L. E, CEGIELSKI, J. P, GRZEMSKA, M, GUPTA, R, ESPINAL, M, LEIMANE, V, WEYER, K, MITNICK, C. D, RIEKSTINA, V, ZAROVSKA, E, RICH, M. L, FRASER, H. S. F, ALARCON, E

    “…SETTING: Globally it is estimated that 273000 new cases of multidrug-resistant tuberculosis (MDR-TB, resistance to isoniazid and rifampicin) occurred in 2000…”
    Get full text
    Journal Article
  5. 5

    Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001 by HOLTZ, T. H, LANCASTER, J, LASERSON, K. F, WELLS, C. D, THORPE, L, WEYER, K

    “…SETTING: Multidrug-resistant tuberculosis (MDR-TB) treatment centers in five provinces, South Africa.OBJECTIVES: To estimate the mortality and evaluate risk…”
    Get full text
    Journal Article
  6. 6

    Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya by van't Hoog, A. H., Williamson, J., Sewe, M., Mboya, P., Odeny, L. O., Agaya, J. A., Amolloh, M., Borgdorff, M. W., Laserson, K. F.

    “…OBJECTIVES: To evaluate excess mortality and risk factors for death during anti-tuberculosis treatment in Western Kenya.METHODS: We abstracted surveillance…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A multicenter evaluation of tuberculin skin test positivity and conversion among health care workers in Brazilian hospitals by ROTH, V. R, GARRETT, D. O, LASERSON, K. F, STARLING, C. E, KRITSKI, A. L, MEDEIROS, E. A. S, BINKIN, N, JARVIS, W. R

    “…SETTING: Four general Brazilian hospitals.OBJECTIVE: To assess the occupational risk of Mycobacterium tuberculosis (TB) in participating hospitals.DESIGN: In…”
    Get full text
    Journal Article
  9. 9

    Reaching the targets for tuberculosis control: the impact of HIV by Laserson, K F, Wells, C D

    Published in Bulletin of the World Health Organization (01-05-2007)
    “…In 1991, the 44th World Health Assembly set two key targets for global tuberculosis (TB) control to be reached by 2000: 70% case detection of acid-fast bacilli…”
    Get full text
    Journal Article
  10. 10

    Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya by Zeh, C., Oyaro, B., Vandenhoudt, H., Amornkul, P., Kasembeli, A., Bondo, P., Mwaengo, D., Thomas, T.K., Hart, C., Laserson, K.F., Ondoa, P., Nkengasong, J.N.

    Published in Journal of virological methods (01-09-2011)
    “…► We retrospectively assessed the performance of six commercial Enzyme Immunoassays. ► Two ELISA/rapid tests selected as alternative algorithms for prospective…”
    Get full text
    Journal Article
  11. 11

    The epidemiology of HIV-associated tuberculosis in rural Cambodia by CAIN, K. P, KANARA, N, LASERSON, K. F, VANNARITH, C, SAMEOURN, K, SAMNANG, K, QUALLS, M. L, WELLS, C. D, VARMA, J. K

    “…SETTING: Banteay Meanchey Province, Cambodia.OBJECTIVE: The World Health Organization recommends human immunodeficiency virus (HIV) testing for all…”
    Get full text
    Journal Article
  12. 12

    Concordance of programmatic and laboratory-based multidrug-resistant tuberculosis treatment outcomes in Peru by Alexy, E. R., Podewils, L. J., Mitnick, C. D., Becerra, M. C., Laserson, K. F., Bonilla, C.

    “…BACKGROUND: Confirmation of cure for multidrug-resistant tuberculosis (MDR-TB) patients requires laboratory tests for Mycobacterium tuberculosis growth on…”
    Get full text
    Journal Article
  13. 13

    Successful use of rifampicin for Hispanic foreign-born patients with latent tuberculosis infection by HALEY, C. A, STEPHAN, S, VOSSEL, L. F, SHERFY, E. A, LASERSON, K. F, KAINER, M. A

    “…SETTING: Four months of rifampicin (4R) is recommended for the treatment of latent tuberculosis infection (LTBI), although data regarding its use are limited…”
    Get full text
    Journal Article
  14. 14

    Substandard tuberculosis drugs on the global market and their simple detection by LASERSON, K. F, KENYON, A. S, KENYON, T. A, LAYLOFF, T, BINKIN, N. J

    “…SETTING: The prevalence of substandard anti-tuberculosis drugs is unknown. To maximize the effectiveness of tuberculosis (TB) control efforts, simple,…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Genetic Characterization of an Epidemic of Plasmodium falciparum Malaria among Yanomami Amerindians by Laserson, K. F., Petralanda, I., Almera, R., Barker, R. H., Spielman, A., Maguire, J. H., Wirth, D. F.

    Published in The Journal of infectious diseases (01-12-1999)
    “…Malaria parasites are genetically diverse at all levels of endemicity. In contrast, the merozoite surface protein (MSP) alleles in samples from 2 isolated…”
    Get full text
    Journal Article
  19. 19
  20. 20

    TST reversion in a BCG-revaccinated population of nursing and medical students, São Paulo, Brazil, 1997-2000 by LEVY, M. Z, MEDEIROS, E. A. S, BINKIN, N, LASERSON, K. F, SHANG, N, SOARES, M. C. S, HOMENKO, A. S, ALMEIDA, R. M, GARRETT, D. O, ROTH, V. R, JARVIS, W. R, WELLS, C. D

    “…SETTING: A major university in São Paulo, Brazil, where vaccination against tuberculosis (TB) with bacille Calmette-Guérin (BCG) was routinely offered to…”
    Get full text
    Journal Article